Cargando…
Osteopontin (OPN) alleviates the progression of osteoarthritis by promoting the anabolism of chondrocytes
Osteoarthritis (OA) is a chronic debilitating joint disease, characterized by degeneration of the cartilage and loss of the cartilage matrix, and it is clinically manifested as joint pain. Osteopontin (OPN) is a glycoprotein that is abnormally expressed in the bone and cartilage tissues and plays a...
Autores principales: | Luo, Wei, Lin, Zili, Yuan, Yuhao, Wu, Ziyi, Zhong, Wei, Liu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311054/ https://www.ncbi.nlm.nih.gov/pubmed/37397527 http://dx.doi.org/10.1016/j.gendis.2022.08.010 |
Ejemplares similares
-
Osteopontin inhibits osteoarthritis progression via the OPN/CD44/PI3K signal axis
por: Liu, Qing, et al.
Publicado: (2020) -
Mechanistic Insight on the Interaction between OPN and Integrin ανβ3 in Osteoarthritis
por: Yuan, Yuhao, et al.
Publicado: (2020) -
DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression
por: Chen, Jinnan, et al.
Publicado: (2023) -
Epigenetic Regulation of Chondrocyte Catabolism and Anabolism in Osteoarthritis
por: Kim, Hyeonkyeong, et al.
Publicado: (2015) -
Osteopontin mediated eosinophils activation by group II innate lymphoid cells
por: Zeng, Qingxiang, et al.
Publicado: (2022)